Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone Acetate in Hormone Refractory Prostate Cancer
NCT00473512Phase 2Completed
- Sponsor
- Cougar Biotechnology
- Start
- Nov 2005
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Abiraterone Acetate Tablets (I) in prostate cancer (PCa), sponsored by Cougar Biotechnology. Primary endpoint: Number of Participants With Confirmed Prostate Specific Antigen (PSA) Response at 12 weeks. Started Nov 2005; status: completed.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00473512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473512.